Chlamydia, or urogenital chlamydia, is a sexually transmitted disease caused by the microorganisms Chlamidia trachomatis, Chlamydia.
According to the world health organization, more than 250 million new episodes of sexually transmitted infections are registered worldwide each year. The leading position in the structure of these diseases belongs to urogenital Chlamydia; about 100 million cases.
Causes and risk factors for Chlamydia in men
The main cause of Chlamydia in men is infection with the Chlamydia trachomatis microorganism during unprotected genital-genital, genital-anal, and oral-genital sexual contact. It is also possible to use a contact-household mechanism of transmission of the pathogen, for example, when visiting a sauna (contact of the genitals with a surface contaminated with Chlamydia).
Chlamydia is an intracellular gram-negative pathogenic agent characterized by a two-phase life cycle in the form of active intra-and inactive extracellular bodies (reticular and elementary bodies, respectively).
Infection occurs when inactive elementary bodies of Chlamydia trachomatis come into contact with the mucous membrane of the genitourinary organs, after which they are embedded in epithelial cells and within 8 hours are transformed into an active reticular form capable of reproduction. Newly formed microorganisms exist in the host cell in isolation inside a special vacuole, these are the so-called Chlamydia inclusions. At the last stage of the breeding cycle active calf go into a downstate, surrounded by a compacted cell wall and violating the integrity of the shell affected cells, back out into the environment, which has introduced new healthy epithelial cells, repeating the cycle of reproduction and thereby spreading the inflammatory process.
The complexity of diagnosis and treatment of Chlamydia in men is due to the intracellular location of the pathogen. When exposed to adverse factors, the microorganism can transform into a “sleeping” form, staying inside the host cells for a long time, without causing an immune response and without provoking symptoms of the disease.
Treatment of Chlamydia in men
The basis of treatment of Chlamydia in men is antibiotic therapy. Currently, the most widely used drugs are the following groups:
In addition to drugs whose action is aimed at eliminating the pathogen, the following drugs are used in the treatment of infection:
- Oriented drugs
- Antioxidants and their synergists
- Proteolytic drugs
- Pre and probiotics
Control of clinical and microbiological criteria for the effectiveness of pharmacotherapy for Chlamydia in men is carried out no earlier than 6-8 weeks after the end of treatment.
During therapy, it is necessary to abandon unprotected sexual acts. a prerequisite for a speedy recovery is the examination of a permanent sexual partner and, if necessary, his parallel treatment.
Symptoms of Chlamydia in men are more pronounced than in women. But even in them, in half of the cases, the clinical manifestations of infection at the initial stages of the disease are either completely absent or extremely weak. This depends on the activity of the pathogen and the body’s immune response to the invasion of pathogenic microorganisms.
The latent course of the disease is particularly dangerous for the male body; late detection of infection significantly complicates therapy, and the consequences of Chlamydia are more severe.